| Chimeric Therapeutics Limited (CHM) ORDINARY FULLY PAID |
Health Care |
$10 |
Appendix 4E and Preliminary Final Report
|
30 Aug 2024 10:04AM |
$0.019 |
$0.003 |
fallen by
84.21%
|
|
CHM - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for ordinary activities remained at zero.
- The company reported a net loss of $12,529,849, down by 51.7% from the previous year.
- No dividends were paid or declared for the current or previous financial year.
- Net assets for the group were $2,470,068 as at 30 June 2024.
- Cash reserves stood at $3,053,001 as at 30 June 2024.
- The company engaged in significant intellectual property acquisitions, including Chlorotoxin CAR-T, CDH-17, and CORE-NK technologies.
- Various milestones and contingent considerations related to intellectual property licenses are detailed.
- The financial statements include a consolidated statement of profit or loss and other comprehensive income, consolidated statement of financial position, and consolidated statement of cash flows.
- The financial report highlights a scale-down of headcount and a reduction in general and administration expenses.
- The financial statements are currently in the process of being audited, with final audited statements expected by 30 September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Danakali Limited (DNK) ORDINARY FULLY PAID |
Materials |
$151 |
Unclaimed Shareholder Distributions
|
30 Aug 2024 10:03AM |
$0.410 |
$0.410 |
fallen by
0%
|
|
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,944 |
Appendix 3C
|
30 Aug 2024 10:01AM |
$42.705 |
$53.170 |
risen by
24.51%
|
|
| RareX Limited (REE) ORDINARY FULLY PAID |
Materials |
$19 |
Cummins Range Development Update
|
30 Aug 2024 10:01AM |
$0.013 |
$0.019 |
risen by
46.15%
|
|
REE - Price-sensitive ASX Announcement
Full Release
Key Points
- Cummins Range is Australia's largest undeveloped rare earth and significant phosphate project
- Rare earths metallurgy and engineering placed on hold until metal prices recover
- Early phosphate product generation being investigated as a standalone stage
- Phosphate metallurgical program has produced samples for testing with offtake market
- Alternative phosphate technology in testing for potential reduction in start-up costs
- Ordco under MoU for Offtake and product R&D which may be supplied with Stage-1 product from alternative technology
- Supply chain to Wyndham Port de-risked with infrastructure sharing agreement
- Native Title heritage agreement discussions ongoing with new representatives
- Development includes leveraging phosphate content as a low capital entrance into operations before expanding into rare earths
- Environmental baseline monitoring completed for pre-engagement with regulators
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pan Asia Metals Limited (PAM) ORDINARY FULLY PAID |
Materials |
$10 |
RK Lithium Project - KT East Geometry Ticks the Boxes
|
30 Aug 2024 10:00AM |
$0.071 |
$0.049 |
fallen by
30.99%
|
|
PAM - Price-sensitive ASX Announcement
Full Release
Key Points
- Soil sampling increases the anomalous lithium zone at KT East.
- The pegmatite field at KT East covers a strike length of 2.1km and width of up to 1.5km.
- The geometry of the pegmatite field is amenable to open pit mining.
- KT East's footprint is larger than both the RK and BT Lithium Prospects combined.
- Further sampling, mapping, and potential trenching are being planned at KT East.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,944 |
Appendix 3C
|
30 Aug 2024 10:00AM |
$42.705 |
$53.170 |
risen by
24.51%
|
|
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$697 |
Change of Director's Interest Notice
|
30 Aug 2024 9:59AM |
$1.650 |
$0.960 |
fallen by
41.82%
|
|
| Halo Technologies Holdings Ltd (HAL) ORDINARY FULLY PAID |
Financials |
$4 |
HALO Invest Business Update
|
30 Aug 2024 9:59AM |
$0.061 |
$0.031 |
fallen by
49.18%
|
|
HAL - Price-sensitive ASX Announcement
Full Release
Key Points
- HALO Invest is establishing a new operations and development center in Glasgow.
- The project is supported by an £800,000 grant from Scottish Enterprise.
- More than 60 jobs are expected to be created over the next two years.
- Douglas Boyce has been appointed Chief Executive Officer of HALO Invest.
- The project is expected to cost around £8 million.
- The launch of HALO Invest in the UK is a key strategic milestone for HALO Technologies Holdings Ltd.
- HALO Invest executed its first trades in the UK, meeting regulatory and infrastructure requirements ahead of schedule.
- HALO is developing services tailored for UK Financial Advisors, including General Investment Accounts, ISAs, and SIPPs.
- HALO Technologies Holdings Ltd is listed on the Australian Securities Exchange and was founded in 2017.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Infinity Mining Limited (IMI) ORDINARY FULLY PAID |
Materials |
$3 |
Chairman's Address for Annual General Meeting
|
30 Aug 2024 9:59AM |
$0.019 |
$0.008 |
fallen by
57.89%
|
|
IMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Infinity Mining Limited is holding its Annual General Meeting with Joe Phillips as the Executive Chairman.
- The company has 100% interest in tenements located in East Pilbara and Central Goldfields regions of Western Australia.
- Focus on lithium exploration in Pilbara tenements.
- Positive exploration results in Pilbara and Central Goldfields for lithium, copper, nickel, and gold.
- In 2023, a successful drilling program yielded an aggregate inferred 60,300 ounces of gold resource.
- New acquisitions in New South Wales, Victoria, and Tasmania for gold, copper, and other base metals.
- Several gold projects in historically productive regions with promising geological settings.
- Projects with diverse mineralisation including copper, tungsten, molybdenum, tin, and other base metals.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Canyon Resources Ltd (CAY) ORDINARY FULLY PAID |
Materials |
$464 |
30 June Quarterly Activities Report Additional Information
|
30 Aug 2024 9:59AM |
$0.078 |
$0.260 |
risen by
233.33%
|
|
| Healius Limited (HLS) ORDINARY FULLY PAID |
Health Care |
$697 |
Change of Director's Interest Notice
|
30 Aug 2024 9:59AM |
$1.650 |
$0.960 |
fallen by
41.82%
|
|
| Shekel Brainweigh Ltd (SBW) ORDINARY FULLY PAID |
Information Technology |
- |
Investor Presentation Webinar
|
30 Aug 2024 9:57AM |
$0.050 |
$0.021 |
fallen by
58%
|
|
| Solis Minerals Ltd (SLM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$15 |
Audited Financial Statements and MD&A for FYE 31 May 2024
|
30 Aug 2024 9:57AM |
$0.090 |
$0.098 |
risen by
8.89%
|
|
| Mosaic Brands Limited (MOZ) ORDINARY FULLY PAID |
Consumer Discretionary |
$6 |
Timing of preliminary financial report
|
30 Aug 2024 9:56AM |
$0.030 |
$0.036 |
risen by
20%
|
|
| Immuron Limited (IMC) ORDINARY FULLY PAID |
Health Care |
$19 |
Appendix 4E and Preliminary Final Report
|
30 Aug 2024 9:56AM |
$0.095 |
$0.069 |
fallen by
27.37%
|
|
IMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported financial loss of A$6.93 million for the year ended 30 June 2024.
- Net assets decreased to A$12.71 million, with cash reserves at A$11.66 million.
- Revenue from ordinary activities increased by 171.7% to A$4.90 million.
- Sales of Travelan® significantly increased in Australia and the USA.
- Completion of Phase 2 clinical trial for IMM-124E.
- Completion of inpatient phase of CampETEC Phase 2 clinical trial.
- Submission of pre-IND application for IMM-529 to the FDA.
- Travelan® clinical field trial reached 77% recruitment.
- U.S. Department of Defense funded research on enhanced formulations of Travelan®.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Maggie Beer Holdings Ltd (MBH) ORDINARY FULLY PAID |
Consumer Staple |
$23 |
FY24 Preliminary Final Report
|
30 Aug 2024 9:56AM |
$0.067 |
$0.066 |
fallen by
1.49%
|
|
MBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenues from ordinary activities increased by 0.8% to $89.4 million.
- The consolidated entity reported a net loss of $28.2 million for the year.
- Significant impairment expenses totaling $18.3 million were recognized.
- Maggie Beer Products saw a 6.3% increase in net sales.
- Hampers & Gifts Australia recorded a 0.7% increase in net sales.
- Paris Creek Farms experienced a 9.5% decline in net sales due to lower milk supply.
- Gross margin decreased by 1.1 percentage points to 49.2%.
- Trading EBITDA was $0.3 million, down from $3.2 million in the previous year.
- The company has no debt and had a net cash position of $4.7 million as of 30 June 2024.
- The company's net assets decreased from $85.7 million to $57.8 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Excelsior Capital Ltd (ECL) ORDINARY FULLY PAID |
Industrials |
$93 |
Earn-out Update
|
30 Aug 2024 9:55AM |
$3.240 |
$3.200 |
fallen by
1.23%
|
|
ECL - Price-sensitive ASX Announcement
Full Release
Key Points
- Excelsior Capital Limited (ECL) provides an update on the earn-out payment related to the sale of CMI Operations Pty Ltd.
- No earn-out payment will be payable to ECL based on IPD Group Limited's full-year reporting.
- ECL has not accrued any earn-out amount in its full-year financial reports.
- ECL has the right to review the income statement and FY24 EBIT calculations of CMI Electrical prepared by IPD.
- ECL is currently reviewing the information provided by IPD.
- Updates will be provided if any changes in relation to the earn-out payment are determined.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Immutep Limited (IMM) ORDINARY FULLY PAID |
Health Care |
$360 |
Appendix 4E & 2024 Full Year Statutory Accounts
|
30 Aug 2024 9:55AM |
$0.388 |
$0.245 |
fallen by
36.77%
|
|
IMM - Price-sensitive ASX Announcement
Full Release
Key Points
- Reported a loss after tax of $42,716,625 for FY2024.
- Raised approximately A$100 million through equity issuance.
- Advanced lead product eftilagimod alpha (efti) in various clinical trials.
- Secured positive regulatory feedback for Phase III TACTI-004 trial in 1L NSCLC.
- Developing LAG-3 agonist IMP761 for autoimmune diseases.
- Entered research collaborations with Monash University and Cardiff University.
- Received grants and increased interest income, contributing to financial position.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Metrics Income Opportunities Trust (MOT) ORDINARY UNITS FULLY PAID |
Financials |
$693 |
Appendix 4G Key to Corporate Governance Disclosure FY 24
|
30 Aug 2024 9:55AM |
$2.190 |
$2.080 |
fallen by
5.02%
|
|
| LiveHire Limited (LVH) ORDINARY FULLY PAID |
Information Technology |
- |
Supplementary Target's Statement
|
30 Aug 2024 9:54AM |
$0.046 |
$0.043 |
fallen by
6.52%
|
|
LVH - Price-sensitive ASX Announcement
Full Release
Key Points
- LiveHire Ltd signed a multi-year contract with the Australian Bureau of Statistics (ABS).
- The ABS contract will generate incremental total revenue of $2,515,932 over the contract period until 31 December 2026.
- LiveHire needs to attain Infosec Registered Assessors Program (IRAP) certification for the ABS contract, which involves significant costs and exposure to material breach conditions.
- LiveHire Directors recommend shareholders accept Humanforce's takeover offer.
- The offer price of $0.045 per share is considered compelling and provides liquidity and certain cash consideration.
- The offer is unconditional and has no superior proposals at the moment.
- All LiveHire Directors have sold their shares to Humanforce and intend to accept the offer for any future shares they acquire.
- The takeover offer by Humanforce is set to close on 30 September 2024 unless extended.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Jayride Group Limited (JAY) ORDINARY FULLY PAID |
Industrials |
$7 |
FY24 Results Overview
|
30 Aug 2024 9:53AM |
$0.010 |
$0.005 |
fallen by
50%
|
|
JAY - Price-sensitive ASX Announcement
Full Release
Key Points
- Initial Strategic Review results in Q4 led to substantial improvements in profitability and cash flows.
- Contribution profit reached a record level of $708K in Q4.
- Fixed cost base was reduced by $922K in Q4, achieving $3.75 million per year in savings.
- FY25 Outlook focuses on long-term growth with a strict focus on profitability.
- Jayride is an online travel marketplace for airport transfers, serving 1,600+ airports in 110+ countries.
- Revenue for FY24 grew to a record $5.39 million.
- Strategic Review identified five key focus areas towards profitability, including cost reductions and improved supplier relationships.
- The company restructured in Q2 and Q3 to create a leaner, more profitable operation.
- Changes to capitalisation policies have been implemented, and all previously capitalised costs are now expensed.
- EBITDA and capitalised technology costs margin improved to -52% in Q4.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Radiopharm Theranostics Limited (RAD) ORDINARY FULLY PAID |
Health Care |
$64 |
Appendix 4E and Preliminary Final Report
|
30 Aug 2024 9:53AM |
$0.034 |
$0.027 |
fallen by
20.59%
|
|
RAD - Price-sensitive ASX Announcement
Full Release
Key Points
- Radiopharm Theranostics Limited released its Appendix 4E and Preliminary Final Report for the year ended 30 June 2024.
- The company reported a net loss of $47,949,119, up 38.5% from the previous year due to increased clinical trial and research activities.
- Revenue from contracts with customers was $299,228.
- Various financial agreements and contingent considerations related to intellectual properties and licenses were detailed, potentially incurring significant future liabilities.
- Net assets decreased to $27,353,286, with cash reserves at $18,575,040.
- No dividends were declared or paid during the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Saferoads Holdings Limited (SRH) ORDINARY FULLY PAID |
Industrials |
$4 |
Preliminary Final Report
|
30 Aug 2024 9:53AM |
$0.041 |
$0.090 |
risen by
119.51%
|
|
SRH - Price-sensitive ASX Announcement
Full Release
Key Points
- Net loss of $3.82 million for the year ending June 30, 2024.
- Revenue from product sales and services totaled $12.59 million, down from $14.65 million in the previous year.
- Total comprehensive loss for the year was $3.82 million, compared to a loss of $197,407 in the previous year.
- Cash flows from operating activities were $1.03 million, down from $2.38 million the year before.
- Impairment of intangible assets amounted to $1.06 million.
- Net tangible asset backing per ordinary share decreased to 10.8 cents from 15.6 cents.
- No dividends declared for the current or previous period.
- The company breached its facility covenants with the Commonwealth Bank at June 30, 2024.
- Total equity decreased to $4.74 million from $8.14 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Carindale Property Trust (CDP) ORDINARY UNITS FULLY PAID |
Real Estate |
$450 |
Application for quotation of securities - CDP
|
30 Aug 2024 9:52AM |
$4.360 |
$5.440 |
risen by
24.77%
|
|
| Dicker Data Limited (DDR) ORDINARY FULLY PAID |
Information Technology |
$1,599 |
H1 FY2024 Results Presentation
|
30 Aug 2024 9:51AM |
$9.790 |
$8.850 |
fallen by
9.60%
|
|
DDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Gross revenue decreased by 0.4% to $1,590.1 million
- Q2 2024 sales growth was 8.3%
- EBITDA decreased by 2.4% to $68.9 million
- Net profit after tax fell by 5.7% to $35.4 million
- Gross profit margin improved to 9.8%
- Increased net working capital and total debt
- Total debt increased by $30.2 million
- Declared dividend increased by 108% to 26.0 cents per share
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
